|
|
Volumn 280, Issue 5367, 1998, Pages 1191-1192
|
|
Building better aspirin: Does aspirin ward off cancer and Alzheimer's?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
ANALGESIA;
ARTHRITIS;
CANCER INHIBITION;
CLINICAL TRIAL;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SELECTIVITY;
DRUG TARGETING;
HUMAN;
KIDNEY INJURY;
NOTE;
PAIN;
PATENT;
PRIORITY JOURNAL;
STOMACH MUCOSA LESION;
STRUCTURE ACTIVITY RELATION;
ALZHEIMER DISEASE;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTICARCINOGENIC AGENTS;
ASPIRIN;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG DESIGN;
FREE RADICALS;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
MICE;
NEOPLASMS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
|
|
EID: 0032557482
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.280.5367.1191 Document Type: Note |
|
Times cited : (49)
|
|
References (0)
|